ESR2 and neoplasm: Replacing bone marrow of wild-type mice with bone marrow from ERβ mutant mice led to fewer tumor-infiltrating CD8+ and CD4+ T cells compared to the control mice, indicating the impaired ability of host immune cells to control tumor growth in the absence of ERβ signaling.